Unimech Aerospace QIP: ₹750 crore plan after Q1 FY27 surge

Board clears ₹750 crore fundraising via QIP

Unimech Aerospace and Manufacturing Limited said its board has approved a plan to raise up to ₹750 crore through a Qualified Institutions Placement (QIP). The fundraising approval comes at a time when the company is highlighting expansion needs and capital requirements for growing operations. A QIP route typically targets institutional investors and is often used to raise growth capital without a public offering process. The company has not detailed the timing, pricing, or tranche structure in the provided information.

Q1 FY27 numbers highlighted: revenue up 71% YoY

Alongside the fundraising decision, the company cited strong consolidated performance for Q1 FY27. Consolidated revenue from operations was reported at ₹107.62 crore, a 71% year-on-year increase. The update attributed the revenue growth to robust aerospace tooling demand. Consolidated net profit for Q1 FY27 was reported at ₹27.86 crore, up from ₹19.10 crore in the same quarter last year. The year-on-year profit growth is described as approximately 45.86%.

Why the QIP matters for an expanding manufacturer

A large QIP approval, relative to recent quarterly revenue levels cited in the material, signals a focus on scaling. For manufacturing businesses serving aerospace tooling and related segments, working capital, capex, and execution capacity often need to rise ahead of demand. The company positioned the QIP as growth capital to finance expanding operations. The combination of a fundraising plan and a strong quarter can also influence how investors assess near-term balance sheet flexibility. However, the eventual impact depends on the final issue size, price, and deployment of proceeds, none of which were specified in the text.

Mixed quarterly datasets in circulation

The information provided also contains other quarterly performance tables that differ from the Q1 FY27 figures cited above. One table labelled “Quarter ended Jun 25” lists Total Revenue at ₹62.99 crore and Net Income at ₹19.12 crore, with a year-on-year comparison shown against ₹59.21 crore revenue and ₹20.63 crore net income. It also shows operating income at ₹13.91 crore for the quarter, and depreciation/amortization of ₹5.89 crore. These numbers sit alongside separate statements that cite Q1 FY27 consolidated revenue of ₹107.62 crore and net profit of ₹27.86 crore.

Street view and estimate ranges cited in the material

The supplied text includes a “Q1 FY27 Estimates” table that projects revenue in the range of ₹85 to ₹98 crore and PAT in the range of ₹15 to ₹19 crore. It also references a July-August 2026 window as an indicative results period for Q1 FY27. In addition, a “12-month target” range of ₹1,363 to ₹1,513 is mentioned as an estimate, and another section cites a 12-month target price of ₹1,590 with a share price around ₹1,150. These are third-party estimate references as presented in the input and not company guidance.

Stock and valuation snapshot mentioned

The material lists the company’s shares trading around ₹1,155 in one section and ₹1,160 in another, with a separate “current price” reference of ₹1,135. Market capitalisation is cited as ₹5,963 crore in one place and ₹5,098 crore in another. One line describes the price-to-earnings multiple as “Not meaningful,” while another states the stock trades at a P/E of 76.8. These snapshots indicate the numbers are drawn from different points or sources in the compiled text.

Historical quarterly trend points included

A consolidated quarterly table spanning Dec 2023 to Mar 2026 shows revenue figures (in ₹ crore) such as 65, 62, 59, 61, 54, 68, 63, 62, 34, and 82 for successive quarters. The same table shows profit after tax values (in ₹ crore) of 20, 20, 21, 18, 16, 29, 19, 16, 2, and 26 across those quarters. It also shows operating margin percentages including 44%, 42%, 43%, 38%, 29%, 40%, 31%, 30%, 5%, and 43. These points indicate earnings can be volatile across quarters even when the business is growing over longer periods.

Timeline markers around earnings updates

The input notes “Last Earnings Date” as 12 February 2026 and also states an “upcoming earnings date” is 12 February 2026. It also mentions an indicative July-August 2026 window for Q1 FY27 results in the estimates section. Because these dates are presented together without reconciliation, readers should treat them as separate schedule references from the compiled dataset. The key takeaway is that results timing is being discussed in the context of the broader quarterly reporting season.

Market impact: growth numbers plus fundraising size

The stated Q1 FY27 performance numbers - revenue of ₹107.62 crore and net profit of ₹27.86 crore - provide the fundamental context for the board’s ₹750 crore QIP approval. If executed, the QIP size is large compared with a single quarter’s revenue scale cited in the same material, which can be meaningful for funding expansion. At the same time, the input also includes a “soft note” commentary for an earlier quarter where Q1 revenue grew 6.4% year-on-year to ₹63.0 crore (₹630 million), and the quarter-end order book was ₹81.0 crore (₹810 million). That contrast underlines why investors typically track both near-term execution and the durability of demand.

Key facts at a glance

What to watch next

The immediate next steps are the formal execution details of the QIP, including final size, pricing, and use of proceeds. Investors will also watch for subsequent quarterly results to validate whether the strong growth cited for Q1 FY27 sustains alongside expansion spending. Separately, the estimates and targets mentioned in the material set expectations that may influence market reactions around the results season. For now, the confirmed update is the board’s approval to raise up to ₹750 crore and the company’s cited Q1 FY27 consolidated revenue and profit growth figures.